CERTIFICATION OF ENROLLMENT
ENGROSSED SUBSTITUTE HOUSE BILL 2115
Chapter 257, Laws of 2024
68TH LEGISLATURE
2024 REGULAR SESSION
ABORTION MEDICATIONS—PRESCRIPTION LABELS WITHOUT PRACTITIONER NAME
EFFECTIVE DATE: June 6, 2024
Passed by the House March 4, 2024 Yeas 61 Nays 36 LAURIE JINKINS
Speaker of the House of Representatives Passed by the Senate February 23, 2024 Yeas 33 Nays 14 DENNY HECK
President of the Senate | CERTIFICATE I, Bernard Dean, Chief Clerk of the House of Representatives of the State of Washington, do hereby certify that the attached is ENGROSSED SUBSTITUTE HOUSE BILL 2115 as passed by the House of Representatives and the Senate on the dates hereon set forth. BERNARD DEAN
Chief Clerk Chief Clerk |
Approved March 26, 2024 9:12 AM | FILED March 27, 2024 |
JAY INSLEE
Governor of the State of Washington | Secretary of State State of Washington |
ENGROSSED SUBSTITUTE HOUSE BILL 2115
AS AMENDED BY THE SENATE
Passed Legislature - 2024 Regular Session
State of Washington | 68th Legislature | 2024 Regular Session |
ByHouse Health Care & Wellness (originally sponsored by Representatives Thai, Slatter, Senn, Chapman, Reed, Ramel, Macri, Gregerson, Doglio, Fosse, Riccelli, Wylie, and Reeves)
READ FIRST TIME 01/22/24.
AN ACT Relating to prescription labels for medications used for abortion; and amending RCW
69.41.050.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
Sec. 1. RCW
69.41.050 and 2003 c 53 s 325 are each amended to read as follows:
(1) To every box, bottle, jar, tube, or other container of a legend drug, which is dispensed by a practitioner authorized to prescribe legend drugs, there shall be affixed a label bearing the name of the prescriber, complete directions for use, the name of the drug either by the brand or generic name and strength per unit dose, name of patient and date: PROVIDED, That the practitioner may omit the name and dosage of the drug if he or she determines that his or her patient should not have this information and that, if the drug dispensed is a trial sample in its original package and which is labeled in accordance with federal law or regulation, there need be set forth additionally only the name of the issuing practitioner and the name of the patient.
(2)(a) Notwithstanding subsection (1) of this section, at a prescriber's request, the prescription label for abortion medications may include the prescribing and dispensing health care facility name instead of the name of the practitioner.
(b) For the purposes of this subsection, "abortion medications" means substances used in the course of medical treatment intended to induce the termination of a pregnancy including, but not limited to, mifepristone.
(3) A violation of this section is a misdemeanor.
Passed by the House March 4, 2024.
Passed by the Senate February 23, 2024.
Approved by the Governor March 26, 2024.
Filed in Office of Secretary of State March 27, 2024.
--- END ---